Study Tempers Promise of Drug for Marfan Syndrome

Tuesday, November 18, 2014 - 13:50 in Health & Medicine

The new study found there was no difference in the aortic growth rate between those taking losartan and those taking the standard treatment.

Read the whole article on NY Times Science

More from NY Times Science

Learn more about

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net